Literature DB >> 19960251

Bismuth salts in the treatment of Helicobacter pylori infection in children.

Selim Gökçe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 19960251     DOI： 10.1007/s10620-009-1077-9

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  12 in total

Review 1.  Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure.

Authors:  J P Gisbert; F Morena
Journal:  Aliment Pharmacol Ther       Date:  2006-01-01       Impact factor: 8.171

2.  Diagnostic accuracy of the C-urea breath test in children: adjustment of the cut-off value according to age.

Authors:  Hye Ran Yang; Jeong Kee Seo
Journal:  J Gastroenterol Hepatol       Date:  2005-02       Impact factor: 4.029

3.  Evaluation of triple and quadruple Helicobacter pylori eradication therapies in Iranian children: a randomized clinical trial.

Authors:  Shahla Bahremand; Laleh Razavi Nematollahi; Hossein Fourutan; Faroukh Tirgari; Shamsollah Nouripour; Elham Mir; Shahriar Aghakhani
Journal:  Eur J Gastroenterol Hepatol       Date:  2006-05       Impact factor: 2.566

4.  Results from the pediatric European register for treatment of Helicobacter pylori (PERTH).

Authors:  Giuseppina Oderda; Peter Shcherbakov; Patrick Bontems; Pedro Urruzuno; Claudio Romano; Frederic Gottrand; M Jose Martinez Gómez; Alberto Ravelli; Paolo Gandullia; Elefteria Roma; Sami Cadranel; Costantino De Giacomo; Roberto Berni Canani; Vincenzo Rutigliano; Ender Pehlivanoglu; Nicolas Kalach; Paola Roggero; Danuta Celinska-Cedro; Brendan Drumm; Thomas Casswall; Marja Ashorn; Sanda Nousia Arvanitakis
Journal:  Helicobacter       Date:  2007-04       Impact factor: 5.753

5.  Nifuratel-containing initial anti-Helicobacter pylori triple therapy in children.

Authors:  Alexander A Nijevitch; Valery U Sataev; Elsa N Akhmadeyeva; Alexander G Arsamastsev
Journal:  Helicobacter       Date:  2007-04       Impact factor: 5.753

6.  Efficacy of bismuth-based triple therapy in children with abdominal pain and Helicobacter pylori gastritis.

Authors:  H Shamaly; D Berkowitz; E Rosenthal; Y Naveh
Journal:  J Pediatr Gastroenterol Nutr       Date:  2000-02       Impact factor: 2.839

7.  How to proceed in Helicobacter pylori-positive chronic gastritis refractory to first- and second-line eradication therapy.

Authors:  Dino Vaira; Chiara Ricci; Alberto Lanzini; Federico Perna; Antonio Romano; Roberto Corinaldesi
Journal:  Dig Dis       Date:  2007       Impact factor: 2.404

8.  In vitro activity of fluoroquinolone and the gyrA gene mutation in Helicobacter pylori strains isolated from children.

Authors:  Shigeru Fujimura; Seiichi Kato; Kazuie Iinuma; Akira Watanabe
Journal:  J Med Microbiol       Date:  2004-10       Impact factor: 2.472

9.  Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis.

Authors:  Richard J Saad; Philip Schoenfeld; Hyungjin Myra Kim; William D Chey
Journal:  Am J Gastroenterol       Date:  2006-03       Impact factor: 10.864

10.  Efficacy of the standard quadruple therapy versus triple therapies containing proton pump inhibitor plus amoxicillin and clarithromycin or amoxicillin-clavulanic acid and metronidazole for Helicobacter pylori eradication in children.

Authors:  Seyed Mohsen Dehghani; Asma Erjaee; Mohammad Hadi Imanieh; Mahmood Haghighat
Journal:  Dig Dis Sci       Date:  2008-11-14       Impact factor: 3.199
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.